NOVO NORDISK A S (NVO) Form 6-K — Oct 26, 2026
Novo Nordisk filed a 6-K detailing progress under its DKK 15 billion share repurchase programme, buying 240,000 B shares per day during the week of 19-23 October 2026 at average prices between DKK 257.23 and DKK 262.77. Since 4 February 2026, the company has repurchased 40,274,179 B shares for DKK 11,187,348,102 at an average price of DKK 277.78, meaning roughly three-quarters of the 12-month programme has already been executed. The company now holds 54,314,876 B shares as treasury stock, about 1.2% of its 4,465,000,000 total shares.
Key figures
- Total shares
- 4465000000
- Treasury shares
- 54314876
- Programme size dkk
- up to DKK 15 billion over 12 months beginning 4 February 2026
- Treasury share pct
- 1.2% of share capital
- Sub programme cap dkk
- DKK 11,200,000,010.45 (6 May 2026 to 1 February 2027)
- Fy2026 average price dkk
- DKK 277.78 per B share
- Fy2026 shares repurchased
- 40274179
- Accumulated programme shares
- 25515000
- Fy2026 repurchases to date dkk
- DKK 11,187,348,102
- Accumulated programme value dkk
- DKK 7,387,348,112
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.